Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Gait analysis in hemiplegic patients using an insole splint

Official title: Gait Analysis in Patients With Hemiplegia Using Insole Splint.

Run by University of Ioannina · NCT05908149 · Data updated 2026-11-12

This study is testing if an insole splint can help improve walking for people with hemiplegia after a stroke.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment12 (estimated)
SponsorUniversity of Ioannina
Academic / other
Locations1 site (Ioannina)
StatusRecruiting
StartedApril 12, 2023
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedDecember 6, 2024
Trial IDNCT05908149 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-70 who have had their first stroke at least two months ago and can walk with or without a splint.

Probably not a fit

Patients with peripheral neurological damage or significant orthopedic issues affecting their gait may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of an insole splint in improving the gait of patients with hemiplegia. Participants will walk in a designated gait analysis area both with and without the insole splint while their muscle activity is monitored using a wireless EMG device. The study seeks to determine if the insole splint leads to measurable improvements in gait and muscle usage. Eligible patients must have experienced their first stroke at least two months prior and be able to walk with or without assistance.

Why it matters

Potential benefit: If successful, this study could lead to improved rehabilitation strategies for hemiplegic patients, enhancing their mobility and quality of life.

How similar studies have gone: While similar studies have explored gait improvement in hemiplegic patients, the specific use of insole splints in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients that can walk with or without the splint, having their first stroke episode at least two months ago and their hospitalisation period does not overcome six months, having also a diagnosis from a neurologist coming with a Brain CT-scan.
* Patients must have use the insole splint during physiotherapy sessions for at least 1 week before their inclusion in the trial.
* Patients must be able to communicate and fully understand the instructions given by the researchers.
* Researchers are going to try to have a sex ratio 50/50.
* Patients' age is going to be between 18-70 years.
* Functional Ambulation Category: FAC \> 2
* Modified Ashworth Scale of the affected lower Limb (MAS): MAS ≤2
* Normal Gait before the stroke.

Exclusion Criteria:

* Peripheral Neurological Damage.
* Past or ongoing orthopedic or reumatologic disease that bothers patient's gait.
* Past damage of the Central Nervous System.
* Dermatologic problems or human factors that limitate the use of insole splint.
* Patients must not have used intramuscular botox injection recently.
* Patients with low motivation and low perception are also excluded.

Where it's running

  • Department of Physical Medicine and Rehabilitation, University Hospital of Ioannina
    Ioannina, Greece
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.